Bentley InnoMed GmbH announced CE Mark approval for the company’s BeGraft Plus for use as a bridging stent graft in bran ...

Additionally, several new trials reporting longer-term follow-up on MICS coronary and valve surgery have demonstrated durable ...

After waiting nearly eight hours for his heart surgery to be performed, his UM surgeon canceled the procedure at the last moment.

RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the Rapid Aortic ...

After years of worsening symptoms, John found answers and lifesaving, specialized aortic care through U of U Health’s ...

JenaValve today announced the completion of the 1,000th commercial procedure using its Trilogy transcatheter heart valve (THV ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced the completion of its 1,000th commercial Trilogy procedure, performed in ...

Caranx Medical announced the first clinical use of its TaviPilot Soft platform for robotic transcatheter aortic valve ...

Intermountain Health has successfully performed the state's first procedure to repair the ascending aorta without major ...

Transcatheter aortic valve implantation (TAVI) for severe, isolated, native aortic regurgitation has been challenging with use of transcatheter heart valves designed for aortic stenosis (off-label use ...

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

ViTAA’s FDA clearance on its AiORTA tool represents the first part of its planned full-suite aortic care platform.